跳至主要内容
临床试验/IRCT201605257513N12
IRCT201605257513N12已完成2 期

Investigation and comparison of the effect of metformin and rosiglitazone alone and in combination on ovarian and endometrium among polycystic ovarian syndrome patients

Vice chancelor of research of Isfahan University of Medical Sciences0 个研究点目标入组 44 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
44

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • females between 18-40 years old; euthyroid; non smoker; normal physical condition; not consumption of drugs that change sexual hormones metabolism for at least 1 month before trial; not using contraceptive pills for at least 3 months before the trial.
  • Exclusion criteria: classic 21_hydroxilase deficiency; hyperprolactinemia; androgen producing tumor; pregnancy; impaired liver tests or kidney function disorder; type 2 Diabetes; anemia; thrombocytopenia; explicit hypertension.

排除标准

  • 未提供

研究者

发起方
Vice chancelor of research of Isfahan University of Medical Sciences

相似试验